Drug intelligence / Profile preview

dextromethorphan and methylphenidate combination

Development stage
Unknown
Modality
Small Molecules
Administration
Oral
01

Overview

The combination of dextromethorphan and methylphenidate is not a standard or approved combination drug product. However, information about the potential interaction between these two medications when taken together can be provided. Dextromethorphan is commonly used as a cough suppressant that works by affecting the brain's cough center. It's found in many over-the-counter cold and cough medications, often in combination with other ingredients like guaifenesin or phenylpropanolamine. Methylphenidate is a central nervous system stimulant used primarily to treat attention deficit hyperactivity disorder (ADHD) and narcolepsy. It works by changing the amounts of certain natural substances in the brain. According to search results, there is limited evidence of direct interaction between dextromethorphan and methylphenidate. One study demonstrated that methylphenidate did not inhibit dextromethorphan metabolism in microsome preparations, suggesting there may not be a significant in vivo interaction between these two drugs. However, this doesn't rule out all potential interactions. When considering these medications together, it's important to note that methylphenidate can interact with other medications and substances. For example, methylphenidate can interact with MAOIs and certain antidepressants, potentially causing increased blood pressure and other adverse effects. If considering taking these medications together, it would be advisable to consult with a healthcare provider, as individual factors and specific formulations could affect potential interactions.

02

Targets

NMDAR (Glutamate receptor ionotropic, NMDA)DAT (Dopamine plasma membrane transport protein)NET (Norepinephrine Transporter)

Beyond the preview

Go deeper on dextromethorphan and methylphenidate combination.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on dextromethorphan and methylphenidate combination.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call